Pulling SEC filings + quote and writing the call…

WESTLAKE CORP
Next earnings Aug 3, 2026 (before open) · consensus $1.82 EPS, $3.28B rev
Last earnings -8.8% on 2026-05-05
Cyclical chemicals maker in a deep trough — a $1.51B loss — but cheap on assets with a survivable balance sheet; a contrarian wait.
Sources: SEC EDGAR (CIK 0001262823, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/21/2026, 8:49:47 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Westlake is a commodity-chemicals and building-products maker mired in a severe cyclical downturn. FY2025 was an outright loss year: revenue fell 8.0% to $11.2B, gross margin collapsed to 7.3% (gross profit -58.5%), operating income swung to -$1.58B, and the company reported a net loss of $1.51B (-$11.70 diluted EPS) versus $602M of profit in FY2024. The five-year history shows the classic chemicals cycle — peak earnings of $2.25B in FY2022 collapsing to losses as pricing and volumes deteriorated. ROE of -17.2% reflects the depth of the trough.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $11.8B | $15.8B | $12.5B | $12.1B | $11.2B |
| Gross profit | $3.50B | $4.07B | $2.22B | $1.96B | $813M |
| Operating income | $2.80B | $3.05B | $729M | $875M | -$1.58B |
| Net income | $2.02B | $2.25B | $479M | $602M | -$1.51B |
| Diluted EPS | $15.58 | $17.34 | $3.70 | $4.64 | -$11.70 |
| Net margin | 17.1% | 14.2% | 3.8% | 5.0% | -13.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1078 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 2 sales
| 2026-05-13 | Bender Mark Steven EVP & CFO | Tax | 5.28K @ $97.34 | $514K |
| 2026-05-12 | Bender Mark Steven EVP & CFO | Exercise | 13.2K | |
| 2026-03-27 | Buesinger Robert F. EVP, PEM Segment Head | Sell | 4.00K @ $115.25 | $461K |
| 2026-03-27 | Bender Mark Steven EVP & CFO | Sell | 16.4K @ $112.54 | $1.85M |
| 2026-02-27 | Bender Mark Steven EVP & CFO | Exercise | 6.20K @ $65.81 | $408K |
| 2026-02-27 | Bender Mark Steven EVP & CFO | Exercise | 6.49K @ $86.54 | $562K |
| 2026-02-27 | Bender Mark Steven EVP & CFO | Disposed (D) | 12.7K @ $98.20 | $1.25M |
| 2026-02-27 | Bender Mark Steven EVP & CFO | Sell | 17.0K @ $100.91 | $1.71M |
| 2026-02-27 | Bender Mark Steven EVP & CFO | Sell | 421.00 @ $101.52 | $42.7K |
| 2026-02-20 | Szwejbka Scott Thomas SVP, HIP Segment Head | Tax | 91.00 @ $94.10 | $8.56K |
| 2026-02-19 | Szwejbka Scott Thomas SVP, HIP Segment Head | Award | 365.00 |